Innovotech Inc.
TSX VENTURE : IOT

Innovotech Inc.

October 31, 2005 13:20 ET

Innovotech Inc.: MBEC Scientists Acknowledged for Biofilm Research in Prestigious American Science Journal

EDMONTON, ALBERTA--(CCNMatthews - Oct. 31, 2005) - Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that scientists from its wholly owned subsidiary, MBEC BioProducts Inc. (MBEC), have been published as the cover article in the November/December 2005 edition of American Scientist. The article describes the ever-present nature of biofilms, how they affect our lives and methods available for identifying and eradicating them. Drs Howard Ceri, co-founder of MBEC and Lyriam Marques, Assistant Research Director of MBEC have co-authored the paper, Biofilms, with Dr Raymond Turner, Associate Professor, University of Calgary and Joe Harrison, doctoral candidate, University of Calgary and NSERC Industrial Studentship with MBEC. The article can be located through the American Scientist website at: www.americanscientist.org/IssueTOC/issue/781 or through the MBEC website at: www.mbec.ca.

About MBEC BioProducts

MBEC's expertise is microbial biofilms, an emerging field in infection and infection control, with implications in microbial resistance, antibiotic development and diagnostic testing. The company's patented technology, the MBEC Assay is a high-throughput system to grow biofilms and screen antimicrobial candidates with anti-biofilm activity. The company uses this technology in its R&D program to develop antimicrobial products and diagnostic tests. The company runs a profitable contract research business, serving the biofilm testing needs of the largest catheter and stent manufacturers in the world.

About Innovotech, Inc

Innovotech Inc. is a public company focused on acquiring novel technologies, or promising technology based companies with an existing or imminent revenue stream. In addition to financial investment in these technologies, Innovotech provides management and technology commercialization expertise.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Innovotech Inc.
    Dr Gerard Tertzakian
    CEO
    (780) 448-0585
    (780) 424-0941 (FAX)
    Website: www.innovotech.ca
    or
    MBEC BioProducts Inc.
    Ken Boutilier
    President
    (780) 425-7717
    (780) 424-0941 (FAX)
    Website: www.mbec.ca